Goetz; Regina

Patent Applications and Registrations

Patent applications and USPTO patent grants for Goetz; Regina.The latest application filed is for "chimeric fibroblast growth factor 19 proteins and methods of use".

Company Profile

1.19.22

Goetz; Regina - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Chimeric fibroblast growth factor 21 proteins and methods of use Grant 10,703,788 - Mohammadi , et al.	2020-07-07
Chimeric fibroblast growth factor 19 proteins and methods of use Grant 10,633,424 - Mohammadi , et al.	2020-04-28
FGF23 c-tail fusion proteins Grant 10,464,979 - Mohammadi , et al. No	2019-11-05
Chimeric fibroblast growth factor 23 proteins and methods of use Grant 10,364,278 - Mohammadi , et al.	2019-07-30
FGF21 protein with enhanced binding affinity for .beta.-Klotho for the treatment of type II diabetes, obesity, and related metabolic disorders Grant 10,174,090 - Mohammadi , et al. J	2019-01-08
Chimeric Fibroblast Growth Factor 21 Proteins And Methods Of Use App 20180186849 - MOHAMMADI; Moosa ; et al.	2018-07-05
Chimeric Fibroblast Growth Factor 19 Proteins And Methods Of Use App 20180186850 - MOHAMMADI; Moosa ; et al.	2018-07-05
Chimeric fibroblast growth factor 21 proteins and methods of use Grant 9,926,355 - Mohammadi , et al. March 27, 2	2018-03-27
Chimeric fibroblast growth factor 19 proteins and methods of use Grant 9,926,356 - Mohammadi , et al. March 27, 2	2018-03-27
Inhibiting binding of FGF23 to the binary FGFR-Klotho complex for the treatment of chronic kidney disease and symptoms and/or complications thereof Grant 9,907,830 - Mohammadi , et al. March 6, 2	2018-03-06
Chimeric Fibroblast Growth Factor 23 Proteins And Methods Of Use App 20170355738 - MOHAMMADI; Moosa ; et al.	2017-12-14
Fgf23 Fusion Proteins App 20170226172 - MOHAMMADI; Moosa ; et al.	2017-08-10
Chimeric fibroblast growth factor 23 proteins and methods of use Grant 9,657,075 - Mohammadi , et al. May 23, 2	2017-05-23
Chimeric Fibroblast Growth Factor 19 Proteins And Methods Of Use App 20170101449 - MOHAMMADI; Moosa ; et al.	2017-04-13
Chimeric Fgf21 Proteins With Enhanced Binding Affinity For Beta-klotho For The Treatment Of Type Ii Diabetes, Obesity, And Related Metabolic Disorders App 20170096462 - Mohammadi; Moosa ; et al.	2017-04-06
Chimeric Fibroblast Growth Factor 21 Proteins And Methods Of Use App 20170029480 - MOHAMMADI; Moosa ; et al.	2017-02-02
Chimeric fibroblast growth factor 23/fibroblast growth factor 19 proteins and methods of use Grant 9,550,820 - Mohammadi , et al. January 24, 2	2017-01-24
Chimeric fibroblast growth factor 19 proteins and methods of use Grant 9,474,785 - Mohammadi , et al. October 25, 2	2016-10-25
Chimeric FGF21 proteins with enhanced binding affinity for .beta.-klotho for the treatment of type II diabetes, obesity, and related metabolic disorders Grant 9,475,856 - Mohammadi , et al. October 25, 2	2016-10-25
Chimeric fibroblast growth factor 21 proteins and methods of use Grant 9,464,126 - Mohammadi , et al. October 11, 2	2016-10-11
Pharmaceutical compositions including a portion of the C-terminus of FGF23 Grant 9,272,017 - Mohammadi , et al. March 1, 2	2016-03-01
Inhibiting binding of FGF23 to the binary FGFR-Klotho complex for the treatment of hypophosphatemia Grant 8,889,621 - Mohammadi , et al. November 18, 2	2014-11-18
Methods of identifying inhibitors of FGF23 binding to the binary FGFR-klotho complex for the treatment of hypophosphatemia Grant 8,889,426 - Mohammadi , et al. November 18, 2	2014-11-18
Chimeric Fibroblast Growth Factor 23 Proteins And Methods Of Use App 20140243260 - MOHAMMADI; Moosa ; et al.	2014-08-28
Chimeric Fibroblast Growth Factor 19 Proteins And Methods Of Use App 20140107022 - MOHAMMADI; Moosa ; et al.	2014-04-17
Chimeric Fibroblast Growth Factor 21 Proteins And Methods Of Use App 20140094406 - MOHAMMADI; Moosa ; et al.	2014-04-03
Chimeric Fibroblast Growth Factor 21 Proteins And Methods Of Use App 20130331316 - MOHAMMADI; Moosa ; et al.	2013-12-12
Chimeric Fibroblast Growth Factor 19 Proteins And Methods Of Use App 20130331317 - MOHAMMADI; Moosa ; et al.	2013-12-12
Chimeric Fibroblast Growth Factor 23 Proteins And Methods Of Use App 20130331325 - MOHAMMADI; Moosa ; et al.	2013-12-12
Chimeric Fgf21 Proteins With Enhanced Binding Affinity For Beta-klotho For The Treatment Of Type Ii Diabetes, Obesity, And Related Metabolic Disorders App 20130231277 - MOHAMMADI; Moosa ; et al.	2013-09-05
Inhibiting Binding Of Fgf23 To The Binary Fgfr-klotho Complex For The Treatment Of Hypophosphatemia App 20130184211 - MOHAMMADI; Moosa ; et al.	2013-07-18
Inhibiting Binding Of Fgf23 To The Binary Fgfr-klotho Complex For The Treatment Of Hypophosphatemia App 20130172275 - MOHAMMADI; Moosa ; et al.	2013-07-04
Inhibiting Binding Of Fgf23 To The Binary Fgfr-klotho Complex For The Treatment Of Hypophosphatemia App 20120288886 - MOHAMMADI; Moosa ; et al.	2012-11-15
Inhibiting Binding Of Fgf23 To The Binary Fgfr-klotho Complex For The Treatment Of Hypophosphatemia App 20110190207 - MOHAMMADI; Moosa ; et al.	2011-08-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.